A detailed history of Arete Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Arete Wealth Advisors, LLC holds 5,438 shares of LLY stock, worth $4.18 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
5,438
Previous 5,438 -0.0%
Holding current value
$4.18 Million
Previous $4.8 Million -0.0%
% of portfolio
0.41%
Previous 0.41%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $1.46 Million - $1.82 Million
-1,894 Reduced 25.83%
5,438 $4.8 Million
Q2 2024

Aug 13, 2024

BUY
$724.87 - $909.04 $5.31 Million - $6.67 Million
7,332 New
7,332 $6.65 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $369,733 - $435,867
704 Added 14.85%
5,445 $3.17 Million
Q3 2023

Oct 30, 2023

SELL
$434.7 - $599.3 $153,883 - $212,152
-354 Reduced 6.95%
4,741 $2.55 Million
Q2 2023

Aug 09, 2023

BUY
$350.74 - $468.98 $236,398 - $316,092
674 Added 15.25%
5,095 $2.39 Million
Q1 2023

May 01, 2023

BUY
$310.63 - $364.82 $195,075 - $229,106
628 Added 16.56%
4,421 $1.52 Million
Q4 2022

Feb 06, 2023

BUY
$321.55 - $374.67 $251,130 - $292,617
781 Added 25.93%
3,793 $1.39 Million
Q3 2022

Nov 07, 2022

BUY
$296.48 - $337.87 $331,168 - $377,400
1,117 Added 58.94%
3,012 $974,000
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $47,384 - $55,635
-170 Reduced 8.23%
1,895 $614,000
Q1 2022

May 06, 2022

BUY
$234.69 - $291.66 $41,774 - $51,915
178 Added 9.43%
2,065 $591,000
Q4 2021

Feb 07, 2022

BUY
$224.85 - $279.04 $115,797 - $143,705
515 Added 37.54%
1,887 $520,000
Q3 2021

Nov 15, 2021

BUY
$221.6 - $272.71 $304,035 - $374,158
1,372 New
1,372 $317,000
Q2 2021

Aug 09, 2021

SELL
$180.55 - $233.54 $258,186 - $333,962
-1,430 Closed
0 $0
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $821 - $1,063
-5 Reduced 0.35%
1,430 $267,000
Q4 2020

Feb 08, 2021

BUY
$130.46 - $172.63 $187,210 - $247,724
1,435 New
1,435 $238,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Arete Wealth Advisors, LLC Portfolio

Follow Arete Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arete Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arete Wealth Advisors, LLC with notifications on news.